Ron Squarer's Net Worth

$26.7 Million

Estimate Recalculated Jun 5, 2025 08:08PM EST

Who is Ron Squarer

Ron Squarer has an estimated net worth of $26.7 Million. This is based on reported shares across multiple companies, which include Travere Therapeutics, Inc., Deciphera Pharmaceuticals, Inc., ARRAY BIOPHARMA INC, HOSPIRA INC, and ADC Therapeutics SA.

SEC CIK

Ron Squarer's CIK is 0001454001

Past Insider Trading and Trends

2017 was Ron Squarer's most active year for acquiring shares with 12 total transactions. Ron Squarer's most active month to acquire stocks was the month of November. 2019 was Ron Squarer's most active year for disposing of shares, totalling 18 transactions. Ron Squarer's most active month to dispose stocks was the month of June. 2017 saw Ron Squarer paying a total of $4,985,625.44 for 1,664,960 shares, this is the most they've acquired in one year. In 2019 Ron Squarer cashed out on 4,562,346 shares for a total of $19,190,816.64, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Travere Therapeutics, Inc.

Investor
Updated May 10, 2024
Form 4
116.20%
26.00K
May 10, 2024
48.38K
Grant
May 08
Form 4
100.70%
18.00K
May 19, 2023
35.88K
Grant
May 17
Form 4
80.67%
12.00K
May 12, 2022
26.88K
Grant
May 11
Form 4
101.05%
12.00K
May 18, 2021
23.88K
Grant
May 14
Form 4
135.21%
12.00K
May 19, 2020
20.88K
Grant
May 15
Form 4
145.45%
10.00K
May 10, 2019
16.88K
Grant
May 08
Form 4
285.71%
12.50K
May 11, 2018
16.88K
Grant
May 09
Form 4
21.88K
Apr 12, 2017
21.88K
Grant
Apr 10
Form 3
Apr 12, 2017
Showing 9 results

Deciphera Pharmaceuticals, Inc.

Investor
Updated Jun 11, 2024
Form 4
-100.00%
-66.07K
Jun 11, 2024
Disposition
Jun 11
Form 4
4.73K
$10.58
$50.00K
Jan 18, 2024
4.73K
Grant
Jan 16
Form 4
30.00K
Jun 23, 2023
30.00K
Grant
Jun 21
Form 4
3.27K
$15.30
$50.00K
Jan 19, 2023
3.27K
Grant
Jan 17
Form 4
18.50K
Jun 24, 2022
18.50K
Grant
Jun 23
Form 4
9.57K
$5.22
$49.96K
Jan 20, 2022
9.57K
Grant
Jan 18
Form 4
12.00K
Jun 25, 2021
12.00K
Grant
Jun 23
Form 4
1.56K
$31.99
$50.00K
Jan 20, 2021
1.56K
Grant
Jan 15
Form 4
723.00
$34.58
$25.00K
Jul 17, 2020
723.00
Grant
Jul 15
Form 4
12.00K
Jun 12, 2020
12.00K
Grant
Jun 10
Form 4/A
21.90K
Feb 20, 2020
21.90K
Grant
Dec 04
Form 4
24.00K
Dec 06, 2019
24.00K
Grant
Dec 04
Form 3
Dec 06, 2019
Showing 13 results

ARRAY BIOPHARMA INC

CEO
Updated Jul 30, 2019
Form 4
-100.00%
-3.86M
$48.00
Jul 30, 2019
Disposition
Jul 30
Form 4
-6.46%
-16.63K
$24.60
-$409.12K
Apr 03, 2019
278.80K
Options
Apr 01
Form 4
-12.30%
-110.00K
$12.63
-$1.98M
Feb 08, 2019
784.53K
Sale
ScheduledFeb 07
Form 4
-17.47%
-213.44K
$11.99
-$2.74M
Feb 01, 2019
1.01M
Sale
ScheduledJan 30 - Jan 31
Form 4
201.78%
770.57K
$15.97
-$340.21K
Dec 18, 2018
1.15M
Options
Dec 14 - Dec 16
Form 4
-25.65%
-218.51K
$13.42
-$2.71M
Jun 29, 2018
633.45K
Sale
ScheduledJun 27
Form 4
-6.24%
-16.61K
$16.32
-$270.99K
Apr 03, 2018
249.39K
Options
Apr 01
Form 4
-5.36%
-130.59K
$8.20
-$4.04M
Dec 19, 2017
2.31M
Sale
ScheduledDec 16 - Dec 19
Form 4/A
-13.18%
-17.56K
$8.94
-$157.01K
Apr 06, 2017
115.68K
Tax
Apr 01
Form 4
-6.58%
-12.04K
$8.94
-$107.66K
Apr 04, 2017
171.05K
Options
Apr 01
Form 4
656.25K
Dec 29, 2016
656.25K
Grant
Dec 27
Form 4
461.88%
523.50K
$3.00
-$17.63K
Apr 05, 2016
636.84K
Grant
Apr 01
Form 4
1,626.79%
529.38K
Apr 03, 2015
561.92K
Grant
Apr 01
Form 4/A
-50.00%
-77.88K
Mar 24, 2015
110.42K
Options
Mar 01
Form 4
-41.70%
-64.95K
$8.05
$91.30K
Mar 04, 2015
90.81K
Sale
Mar 01 - Mar 02
Form 4
155.76K
Aug 20, 2014
155.76K
Grant
Aug 18
Form 4
425.00K
Apr 03, 2014
425.00K
Grant
Apr 01
Form 4
350.00K
May 07, 2013
350.00K
Grant
May 03
Form 4
4.40K
Oct 05, 2012
4.40K
Grant
Oct 04
Form 3
Apr 30, 2012
Showing 20 results

HOSPIRA INC

Chief Commercial Officer
Updated Feb 28, 2011
Form 4
492.14%
35.45K
$52.46
-$126.22K
Feb 28, 2011
60.53K
Options
Feb 24
Form 4
-28.97%
-30.68K
$43.70
-$642.11K
Jul 07, 2010
75.23K
Sale
ScheduledJun 23 - Jul 06
Form 4
-31.22%
-3.12K
$56.86
-$177.52K
Apr 01, 2010
9.88K
Tax
Mar 30
Form 4
8,349.60%
57.19K
Feb 16, 2010
57.88K
Grant
Feb 11
Form 4
76.71K
Mar 09, 2009
76.71K
Grant
Mar 05
Form 4
3.00K
$24.80
$74.40K
Feb 26, 2009
13.00K
Purchase
Feb 25
Form 3
Jan 20, 2009
10.00K
Showing 7 results

ADC Therapeutics SA

Investor
Updated Jun 05, 2025
Form 3/A
Jun 05, 2025
35.81K
Form 4
-7.98%
-7.00K
$2.89
-$20.22K
Jun 18, 2024
80.66K
Sale
Jun 17
Form 4
83.93%
40.00K
Jun 14, 2024
87.66K
Grant
Jun 13
Form 3
Jan 02, 2024
47.66K
Showing 4 results